These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 23564776

  • 1. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
    Shishido Y, Ueno S, Yamazaki R, Nagaoka M, Matsuzaki T.
    Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
    [Abstract] [Full Text] [Related]

  • 2. Novel acrylonitrile derivatives, YHO-13177 and YHO-13351, reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
    Yamazaki R, Nishiyama Y, Furuta T, Hatano H, Igarashi Y, Asakawa N, Kodaira H, Takahashi H, Aiyama R, Matsuzaki T, Yagi N, Sugimoto Y.
    Mol Cancer Ther; 2011 Jul; 10(7):1252-63. PubMed ID: 21566063
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK, Poon DC, Wei Y, Wang F, Lin G, Fu LW.
    Biochem Pharmacol; 2015 Sep 01; 97(1):27-37. PubMed ID: 26206183
    [Abstract] [Full Text] [Related]

  • 5. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
    Westover D, Ling X, Lam H, Welch J, Jin C, Gongora C, Del Rio M, Wani M, Li F.
    Mol Cancer; 2015 Apr 28; 14():92. PubMed ID: 25928015
    [Abstract] [Full Text] [Related]

  • 6. Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.
    Katayama R, Koike S, Sato S, Sugimoto Y, Tsuruo T, Fujita N.
    Cancer Sci; 2009 Nov 28; 100(11):2060-8. PubMed ID: 19673889
    [Abstract] [Full Text] [Related]

  • 7. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
    Yanamoto S, Kawasaki G, Yamada S, Yoshitomi I, Kawano T, Yonezawa H, Rokutanda S, Naruse T, Umeda M.
    Oral Oncol; 2011 Sep 28; 47(9):855-60. PubMed ID: 21757396
    [Abstract] [Full Text] [Related]

  • 8. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
    Zhang QH, Dou HT, Xu P, Zhuang SC, Liu PS.
    Drug Res (Stuttg); 2015 Mar 28; 65(3):153-7. PubMed ID: 25504004
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
    Luo LJ, Zhao Z, Zeng JF, Liang B, Yang JX, Cao DY, Shen K.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 28; 47(4):281-5. PubMed ID: 22781115
    [Abstract] [Full Text] [Related]

  • 10. A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma.
    Yashiro M, Nishii T, Hasegawa T, Matsuzaki T, Morisaki T, Fukuoka T, Hirakawa K.
    Br J Cancer; 2013 Nov 12; 109(10):2619-28. PubMed ID: 24129235
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
    Mishra MN, Vangara KK, Palakurthi S.
    Anticancer Res; 2014 Nov 12; 34(11):6345-51. PubMed ID: 25368234
    [Abstract] [Full Text] [Related]

  • 14. Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line.
    Dou J, Jiang C, Wang J, Zhang X, Zhao F, Hu W, He X, Li X, Zou D, Gu N.
    Cell Biol Int; 2011 Mar 12; 35(3):227-34. PubMed ID: 21108606
    [Abstract] [Full Text] [Related]

  • 15. Gefitinib enhances the antitumor activity and oral bioavailability of irinotecan in mice.
    Stewart CF, Leggas M, Schuetz JD, Panetta JC, Cheshire PJ, Peterson J, Daw N, Jenkins JJ, Gilbertson R, Germain GS, Harwood FC, Houghton PJ.
    Cancer Res; 2004 Oct 15; 64(20):7491-9. PubMed ID: 15492275
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
    Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM.
    Arch Otolaryngol Head Neck Surg; 2007 Oct 15; 133(10):1022-7. PubMed ID: 17938326
    [Abstract] [Full Text] [Related]

  • 18. Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.
    Hu J, Li J, Yue X, Wang JC, Wang JF, Liu JZ, Kong DL.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr 15; 37(2):231-236. PubMed ID: 28397046
    [Abstract] [Full Text] [Related]

  • 19. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L.
    Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876
    [Abstract] [Full Text] [Related]

  • 20. Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma.
    Guan GF, Zhang DJ, Zheng Y, Wen LJ, Yu DJ, Lu YQ, Zhao Y.
    Mol Med Rep; 2015 Sep 29; 12(3):4352-4357. PubMed ID: 26081022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.